Clinical effects of intensive insulin therapy treating traumatic shock combined with multiple organ dysfunction syndrome

Abstract

The therapeutic effects of intensive insulin therapy in treatment of traumatic shock combined with multiple organ dysfunction syndrome (MODS) were investigated. A total of 114 patients with traumatic shock combined with MODS were randomly divided into two groups: control group (n=56) treated with conventional therapy, and intensive insulin therapy group (n=58) treated with conventional therapy plus continuous insulin pumping to control the blood glucose level at range of 4.4–6.1 mmol/L. White blood cells (WBC) counts, prothrombin time (PT), serum creatinine (SCr), alanine aminotransferase (ALT), serum albumin and PaO₂ were measured before and at the day 1, 3, 5, 7 and 14 after treatment. The incidence of gastrointestinal dysfunction, the incidence of MODS, hospital stay and the mortality were also observed and compared. After intensive insulin therapy, the WBC counts, SCr, ALT and PT were significantly reduced (P<0.05), but the level of serum albumin was significantly increased (P<0.05) at the day 3, 5, 7 and 14. In the meantime, the PaO2 was significantly elevated at the day 3, 5 and 7 (P<0.01) after intensive insulin therapy. The incidence of gastrointestinal dysfunction, the incidence of MODS, the length of hospital stay and the mortality were markedly decreased (P<0.01). The results suggest early treatment with intensive insulin therapy is effective for traumatic shock combined with MODS and can decrease the length of hospital stay and the mortality.

Keywords

intensive insulin therapy / traumatic shock / multiple organ dysfunction syndrome

References

[1] DaviesM.G., HagenP.O.. Systemic inflammatory response syndrome. Br J Surg, 1997, 84(7): 920-935

[2] McCowenK.C., MalhotraA., BistrianB.R.. Stress-induced hyperglycemia. Crit Care Clin, 2001, 17(1): 107-124

[3] Van Den BergheG., WoutersP., WeekersF., et al.. Intensive insulin therapy in critically ill patients. N Eng1 J Med, 2001, 345(19): 1359-1367

[4] HardawayR.M.. Traumatic shock alias posttrauma critical illness. Am Surg, 2000, 66(3): 284-290

[5] MarshallJ.C., CookD.J., ChristonN.V., et al.. Multiple organ dysfunction score: a reliable descriptor of complex clinical outcome. Crit Care Med, 1995, 2(10): 1638-1652

[6] GorisR.J., te BoekhorstT.P., NuytinckJ.K., et al.. Multiple organ failure: generalize autodestructive inflammation?. Arch Surg, 1985, 120(10): 1109-1115

[7] FuW.J., TengQ.S., LiT.S., et al.. Fluid resuscitation in traumatic shock. Zhong Guo Wei Zhong Bing Ji Jiu Yi Xue (Chinese), 2003, 15(12): 739-741

[8] LinE., CalavoS.E., LowryS.E.. Inflammatory cytokines and cell response in surgery. Surgery, 2000, 127(2): 117-126

[9] RassiasA.J., MarrinC.A., ArrudaJ., et al.. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Aensth Analg, 1999, 88(5): 1011-1016

[10] AvignonA., MonnierL.. Insulin sensitivity and stress. Diabetes Metab, 2001, 27(2Pt2): 233-238

[11] EspositoK., NappoF., MarfellR., et al.. Inflammatory cytokines and cell response in surgery concentrations are acutely increased by hyperglycemia in human role of oxidative stress. Circulation, 2002, 106(16): 2067-2072

[12] MesottenD., SwinnenJ.V., VanderhoydoncF., et al.. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab, 2004, 89(1): 219-226

[13] SatomiN., SakuraiA., HaranakaK., et al.. Relationship of hypoglycemia to tumor necrosis factor production and antitumor activity: role of glucose, insulin, and macrophages. J Natl Cancer Inst, 1985, 74(6): 1255

[14] DasU.N.. Is insulin an anti inflammation molecule. Nutrition, 2001, 17(5): 409

[15] Sanchez-ZamoraY., TerrazasL.I., Vilches-FloresA., et al.. Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitus. FASEB J, 2010, 24(7): 2583-2590

[16] VincentJ.L., NavickisR.J., WilkesM.M.. Morbidity in hospitalized patients receiving human albumin: A meta-analysis of randomized, controlled trials. Crit Care Med, 2004, 32(10): 2029-2038

[17] NormanJ.. The role of cytokine in the pathogensis of acute pancreatitis. Am J Surg, 1998, 175(2): 76

[18] BaueA.E.. Predicting outcome in injured patients and its relationship to circulating cytokines. Shock, 1995, 4(1): 39-40

[19] DasU.N.. Is insulin an endogenous cardio protector. Crit Care, 2002, 6(5): 389-393

[20] BegerH.G., RauB.M.. Severe pancreatitis: clinical course and management. World J Gastroenterol, 2007, 13(39): 5043

[21] TreggiariM.M., KarirV., YanezN.D., et al.. Intensive insulin therapy and mortality in critically ill patients. Crit Care Med, 2008, 12(1): R29